Vanguard Group Inc Biodesix Inc Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Biodesix Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,906,504 shares of BDSX stock, worth $5.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,906,504

Previous 807,928 259.75%

Holding current value

$5.12 Million

Previous $1.16 Million 284.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.21 - $1.71 $2.54 Million - $3.59 Million	2,098,576 Added 259.75%	2,906,504 $4.45 Million
Q1 2024 May 10, 2024	SELL	$1.35 - $2.12 $5,161 - $8,104	-3,823 Reduced 0.47%	807,928 $1.16 Million
Q4 2023 Feb 14, 2024	SELL	$1.2 - $2.13 $252,105 - $447,487	-210,088 Reduced 20.56%	811,751 $1.49 Million
Q3 2023 Nov 14, 2023	SELL	$1.04 - $1.74 $281,424 - $470,844	-270,600 Reduced 20.94%	1,021,839 $1.69 Million
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.88 $68,988 - $115,802	61,597 Added 5.0%	1,292,439 $1.59 Million
Q1 2023 May 15, 2023	BUY	$1.52 - $2.5 $189,147 - $311,097	124,439 Added 11.25%	1,230,842 $2.29 Million
Q4 2022 Feb 10, 2023	BUY	$0.98 - $2.3 $849,412 - $1.99 Million	866,747 Added 361.66%	1,106,403 $2.54 Million
Q3 2022 Nov 14, 2022	BUY	$1.24 - $2.89 $73,978 - $172,417	59,660 Added 33.15%	239,656 $305,000
Q2 2022 Aug 12, 2022	SELL	$1.32 - $2.12 $52,743 - $84,708	-39,957 Reduced 18.17%	179,996 $295,000
Q1 2022 May 13, 2022	SELL	$1.69 - $5.81 $263,871 - $907,155	-156,137 Reduced 41.52%	219,953 $372,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $8.67 $539 - $1,144	132 Added 0.04%	376,090 $1.99 Million
Q3 2021 Nov 12, 2021	BUY	$6.6 - $12.78 $78,031 - $151,097	11,823 Added 3.25%	375,958 $3.09 Million
Q2 2021 Aug 13, 2021	BUY	$12.14 - $20.35 $4.42 Million - $7.41 Million	364,135 New	364,135 $4.81 Million

Others Institutions Holding BDSX

# of Institutions

Shares Held

53.6M

Call Options Held

500

Put Options Held

11.5K

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $70.4M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Biodesix Inc Transaction History